超声引导下射频治疗仪治疗子宫肌瘤的临床观察  

Clinical Observation on the Treatment of Uterine Fibroids with Ultrasound-Guided Radiofrequency Therapeutic Apparatus

作　　者：王雪 WANG Xue(Chaoyang Central Hospital,Liaoning Chaoyang 122000)

机构地区：[1]朝阳市中心医院,辽宁朝阳122000

出　　处：《中国医疗器械信息》2022年第16期89-91,共3页China Medical Device Information

摘　　要：目的:探究超声引导下射频治疗仪治疗子宫肌瘤的实施效果。方法:随机抽取本院96例子宫肌瘤患者,利用摸球法分为研究组(使用超声引导下射频治疗仪治疗)与对照组(使用米非司酮常规药物治疗)。对比分析两组的治疗效果。结果:经治疗干预,研究组子宫肌瘤体积及血红蛋白水平明显优于对照组;相较于对照组,研究组患者的血清激素水平更优,差异具有统计学意义,P<0.05。两组不良反应发生情况比较,对照组不良反应发生率为20.83%,研究组不良反应发生率为8.33%,研究组更低,P<0.05。结论:相较于米非司酮常规药物治疗,对子宫肌瘤患者使用超声引导下射频治疗仪治疗,可以有效改善患者肺功能,使患者子宫肌瘤的体积得到缩小,优化患者血红蛋白以及血清激素水平,且药物安全性高,不良反应发生率低。Objective:To explore the effect of ultrasound-guided radiofrequency therapy in the treatment of uterine leiomyoma.Methods:96 patients with uterine fibroids were randomly selected and divided into study group(treated with ultrasound-guided radiofrequency therapeutic apparatus)and control group(treated with conventional mifepristone).The therapeutic effects of the two groups were compared and analyzed.Results:After treatment intervention,the uterine fibroid volume and hemoglobin level of the study group were significantly better than those of the control group;The serum hormone level of the study group was significantly better than that of the control group;The difference between the two groups was significant(P<0.05).Comparing the incidence of adverse reactions between the two groups,the incidence of adverse reactions in the control group was 20.83%,and the incidence of adverse reactions in the study group was 8.33%,which was even lower in the study group,P<0.05.Conclusion:Compared with mifepristone conventional drug treatment,the use of ultrasound-guided radiofrequency therapy for patients with uterine fibroids achieved good therapeutic effect,significantly reduced the volume of uterine fibroids,improved hemoglobin and serum hormone levels,and high drug safety,low incidence of adverse reactions.

关 键 词：超声引导 射频治疗仪 子宫肌瘤 

分 类 号：R737.33[医药卫生—肿瘤]